Table 2.

Difference in expression of monocarboxylate transporters (MCTs) and CD147 in tumors in relation to the clinical stage.

Gene	Difference in Expression (Fold Change)
	Stage II versus 0/I	Stage III versus II	Stage III versus 0/I	p *
MCT1	0.65 (0.43–0.98)	27.46 (18.12–41.62)	17.78 (11.73–26.25)	0.149
MCT4	7.12 (4.7–10.8)	1.25 (0.67–2.32)	8.89 (5.86–13.47)	0.433
CD147	3.70 (3.23–4.26)	1.84 (1.60–2.11)	6.83 (5.95–7.85)	0.050

* Kruskal–Wallis.